These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37499987)
1. Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators. Detta E; Corcuera A; Urban A; Goldner T; Bonsmann S; Engel F; May MM; Buschmann H; Fianchini M; Alza E; Pericàs MA; Pushkarev PA; Varenyk AO; Yakovyuk TY; Homon AA; Sokoliuk PA; Smaliy R; Donald A Bioorg Med Chem Lett; 2023 Sep; 93():129412. PubMed ID: 37499987 [TBL] [Abstract][Full Text] [Related]
2. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches. Senaweera S; Du H; Zhang H; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z Viruses; 2021 Apr; 13(5):. PubMed ID: 33925540 [TBL] [Abstract][Full Text] [Related]
3. Structure-Based Discovery of Yang Y; Yan Y; Yin J; Hu J; Cai X; Hu J; Xia J; Wang K; Tang N; Huang L Viruses; 2022 Feb; 14(2):. PubMed ID: 35215939 [TBL] [Abstract][Full Text] [Related]
4. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus. Berke JM; Dehertogh P; Vergauwen K; Van Damme E; Mostmans W; Vandyck K; Pauwels F Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584155 [TBL] [Abstract][Full Text] [Related]
5. Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy. Kim H; Ko C; Lee JY; Kim M Molecules; 2021 Dec; 26(24):. PubMed ID: 34946502 [TBL] [Abstract][Full Text] [Related]
6. The Mechanism of Action of Hepatitis B Virus Capsid Assembly Modulators Can Be Predicted from Binding to Early Assembly Intermediates. Pavlova A; Bassit L; Cox BD; Korablyov M; Chipot C; Patel D; Lynch DL; Amblard F; Schinazi RF; Gumbart JC J Med Chem; 2022 Mar; 65(6):4854-4864. PubMed ID: 35290049 [TBL] [Abstract][Full Text] [Related]
7. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle. Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770 [TBL] [Abstract][Full Text] [Related]
8. Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays. Wang Y; Wang Z; Liu J; Wang Y; Wu R; Sheng R; Hou T Bioorg Med Chem; 2021 Apr; 36():116096. PubMed ID: 33721800 [TBL] [Abstract][Full Text] [Related]
9. Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives. Yang L; Liu F; Tong X; Hoffmann D; Zuo J; Lu M ACS Infect Dis; 2019 May; 5(5):713-724. PubMed ID: 30896149 [TBL] [Abstract][Full Text] [Related]
10. Discovery of (1 Wang C; Pei Y; Wang L; Li S; Jiang C; Tan X; Dong Y; Xiang Y; Ma Y; Liu G J Med Chem; 2020 Jun; 63(11):6066-6089. PubMed ID: 32421339 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors. Liu L; Wang M; Li C; Han X; Xie Y; Feng K; Zhang L; Chen Y; Jia H Bioorg Chem; 2022 Nov; 128():106052. PubMed ID: 35921789 [TBL] [Abstract][Full Text] [Related]
12. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly. Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of highly potent HBV capsid assembly modulators (CAMs). Amblard F; Chen Z; Wiseman J; Zhou S; Liu P; Salman M; Verma K; Azadi N; Downs-Bowen J; Tao S; Kumari A; Zhang Q; Smith DB; Patel D; Bassit L; Schinazi RF Bioorg Chem; 2023 Dec; 141():106923. PubMed ID: 37871391 [TBL] [Abstract][Full Text] [Related]
14. Discovery of 5-alkyl-2-pyrazol-oxazolidin-4-one derivatives as novel hepatitis B virus capsid assembly modulators. Guan M; Wang Y; Wang Y; Chen N; Shi S; Sheng R Arch Pharm (Weinheim); 2023 Jun; 356(6):e2200592. PubMed ID: 37021586 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors. Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants. Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265 [TBL] [Abstract][Full Text] [Related]
17. A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly. Xi J; Gu Z; Sun C; Chen Z; Zhang T; Chen R; Liu T; Liao H; Zou J; Yang D; Xu Q; Wang J; Wei G; Cheng Z; Lu F; Chen X Antiviral Res; 2023 Oct; 218():105715. PubMed ID: 37683938 [TBL] [Abstract][Full Text] [Related]
18. Development of benzimidazole-based compounds as novel capsid assembly modulators for the treatment of HBV infection. Du K; Wang X; Bai Y; Zhang X; Xue J; Li S; Xie Y; Sang Z; Tang Y; Wang X Eur J Med Chem; 2024 May; 271():116402. PubMed ID: 38636128 [TBL] [Abstract][Full Text] [Related]